Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
DermaXon Logo
DermaXon CB Rank
579317
Heat Score
72
DermaXon is a drug discovery and development company.
Founded
obfuscation
Private Missoula, Montana, United States1-10 dermaxon.com
Biopharma
Biotechnology
Health Care
Medical
Overview

DermaXon
Heat Score
72

Growth Score
pts
in past quarter
Heat Score 72
6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About DermaXon

CB Rank
579317
DermaXon is a drug discovery and development company.
Founded
obfuscation
Private Missoula, Montana, United States1-10 dermaxon.com
Biopharma
Biotechnology
Health Care
Medical

Key People

  • Photo of Philippe Diaz
    Philippe Diaz: Co founder
    Past Role: The University of Texas M.D. Anderson Cancer Center, Sr Research scientist

Details

Operating Status Active
Company Type For Profit
Founders  Philippe Diaz
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

DX308
A selective CYP26 inhibitor designed for topical treatment of ichthyosis by increasing endogenous retinoic acid levels without activating retinoic acid receptors.
DX314
A CYP26B1-selective inhibitor developed as a potential therapeutic for keratinization disorders by modulating retinoic acid metabolism.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

167
-60.98%
 in past month

IT Spend

$73.1KThis year, DermaXon is projected to spend $73.1K on IT, according to Aberdeen.

Active Website Tech Count

3DermaXon is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Gravatar Profiles.
Sub-Organizations
Frequently Asked Questions

Where is DermaXon's headquarters? DermaXon is located in Missoula, Montana, United States.Who are DermaXon's competitors? Alternatives and possible competitors to DermaXon may include Amgen, Climb Bio, and  Nimbus Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(64a2f73 1)
|